Grandview Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,400
Closed -$372K 144
2025
Q2
$372K Sell
5,400
-1,000
-16% -$65.6K 0.12% 99
2025
Q1
$434K Sell
6,400
-535
-8% -$32K 0.16% 80
2024
Q4
$311K Buy
+6,935
New +$389K 0.11% 96
2024
Q2
Sell
-3,504
Closed -$279K 65
2024
Q1
$279K Buy
3,504
+1
+0% +$76 0.13% 94
2023
Q4
$277K Sell
3,503
-99
-3% -$7.05K 0.15% 91
2023
Q3
$251K Buy
+3,602
New +$255K 0.14% 97
2023
Q2
Sell
-4,679
Closed -$348K 72
2023
Q1
$348K Buy
4,679
+2
+0% +$168 0.2% 85
2022
Q4
$436K Buy
4,677
+1
+0% +$96 0.27% 75
2022
Q3
$446K Buy
4,676
+2
+0% +$198 0.28% 69
2022
Q2
$433K Sell
4,674
-251
-5% -$24.5K 0.24% 74
2022
Q1
$498K Sell
4,925
-3,048
-38% -$320K 0.21% 83
2021
Q4
$823K Buy
+7,973
New +$737K 0.33% 67
2021
Q3
Sell
-9,023
Closed -$753K 76
2021
Q2
$753K Buy
9,023
+18
+0.2% +$1.47K 0.41% 57
2021
Q1
$677K Buy
9,005
+1,450
+19% +$106K 0.36% 66
2020
Q4
$516K Buy
+7,555
New +$491K 0.34% 70

Other funds holding CVS

Grandview Asset Management's CVS Position: Q3 2025 in Review

Grandview Asset Management sold out of CVS Health (CVS) in Q3 2025, closing a stake of 5,400 shares — an estimated $372K sold.

Grandview Asset Management first reported a position in CVS in Q4 2020 and held it in 15 quarters. The position peaked at $823K in Q4 2021. 1,834 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • Grandview Asset Management reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
  • Grandview Asset Management sold 5,400 CVS Health shares in Q3 2025, an estimated $372K.
  • Grandview Asset Management first reported a position in CVS Health in Q4 2020 and held it in 15 quarters.
  • Grandview Asset Management's CVS Health position peaked at $823K in Q4 2021.
  • 1,834 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Grandview Asset Management's 13F filing for Q3 2025, filed 22 Oct 2025.